Connection
Kian Behbakht to Receptors, Urokinase Plasminogen Activator
This is a "connection" page, showing publications Kian Behbakht has written about Receptors, Urokinase Plasminogen Activator.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.020 |
|
|
|
-
Ghamande SA, Silverman MH, Huh W, Behbakht K, Ball G, Cuasay L, W?rtz SO, Brunner N, Gold MA. A phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous A6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer. Gynecol Oncol. 2008 Oct; 111(1):89-94.
Score: 0.020